Genome-Wide Sequencing Reveals MicroRNAs Downregulated in Cerebral Cavernous Malformations
- 484 Downloads
Cerebral cavernous malformations (CCM) are vascular lesions associated with loss-of-function mutations in one of the three genes encoding KRIT1 (CCM1), CCM2, and PDCD10. Recent understanding of the molecular mechanisms that lead to CCM development is limited. The role of microRNAs (miRNAs) has been demonstrated in vascular pathologies resulting in loss of tight junction proteins, increased vascular permeability and endothelial cell dysfunction. Since the relevance of miRNAs in CCM pathophysiology has not been elucidated, the primary aim of the study was to identify the miRNA-mRNA expression network associated with CCM. Using small RNA sequencing, we identified a total of 764 matured miRNAs expressed in CCM patients compared to the healthy brains. The expression of the selected miRNAs was validated by qRT-PCR, and the results were found to be consistent with the sequencing data. Upon application of additional statistical stringency, five miRNAs (let-7b-5p, miR-361-5p, miR-370-3p, miR-181a-2-3p, and miR-95-3p) were prioritized to be top CCM-relevant miRNAs. Further in silico analyses revealed that the prioritized miRNAs have a direct functional relation with mRNAs, such as MIB1, HIF1A, PDCD10, TJP1, OCLN, HES1, MAPK1, VEGFA, EGFL7, NF1, and ENG, which are previously characterized as key regulators of CCM pathology. To date, this is the first study to investigate the role of miRNAs in CCM pathology. By employing cutting edge molecular and in silico analyses on clinical samples, the current study reports global miRNA expression changes in CCM patients and provides a rich source of data set to understand detailed molecular machinery involved in CCM pathophysiology.
KeywordsCerebral cavernous malformations MicroRNAs Vascular Pathology In silico analyses Sequencing
The authors are thankful to the Research Core Unit Transcriptomics (RCUT) of Hannover Medical School for their technical assistance and support with regard to RNA isolation from brain tissue samples.
Compliance with Ethical Standards
The study was performed in accordance with the guidelines and with permission by the Ethical Committee of the Hannover Medical School, Germany (Approval Number 6960).
Conflict of Interest
The authors declare that they have no conflict of interest.
- Benjamini Y, Hochberg Y (1995) "Controlling the false discovery rate: a practical and powerful approach to multiple testing." Journal of the Royal Statistical Society. Series B (Methodological) 57(1):289–300Google Scholar
- Bergametti F, Denier C, Labauge P, Arnoult M, Boetto S, Clanet M, Coubes P, Echenne B, Ibrahim R, Irthum B, Jacquet G, Lonjon M, Moreau JJ, Neau JP, Parker F, Tremoulet M, Tournier-Lasserve E, N. Societe Francaise de (2005) Mutations within the programmed cell death 10 gene cause cerebral cavernous malformations. Am J Hum Genet 76(1):42–51CrossRefPubMedGoogle Scholar
- Chen Z, Lai TC, Jan YH, Lin FM, Wang WC, Xiao H, Wang YT, Sun W, Cui X, Li YS, Fang T, Zhao H, Padmanabhan C, Sun R, Wang DL, Jin H, Chau GY, Huang HD, Hsiao M, Shyy JY (2013) Hypoxia-responsive miRNAs target argonaute 1 to promote angiogenesis. J Clin Invest 123(3):1057–1067CrossRefPubMedPubMedCentralGoogle Scholar
- Kar, S., A. Baisantry, A. Nabavi and H. Bertalanffy (2016). "Role of Delta-Notch signaling in cerebral cavernous malformations." Neurosurg RevGoogle Scholar
- Li, P., M. Shen, F. Gao, J. Wu, J. Zhang, F. Teng and C. Zhang (2016). "An antagomir to microRNA-106b-5p ameliorates cerebral ischemia and reperfusion injury in rats via inhibiting apoptosis and oxidative stress." Mol NeurobiolGoogle Scholar
- Motameny S, Wolters S, Nurnberg P, Schumacher B (2010) Next generation sequencing of miRNAs - strategies, resources and methods. Genes (Basel) 1(1):70–84Google Scholar
- Renz M, Otten C, Faurobert E, Rudolph F, Zhu Y, Boulday G, Duchene J, Mickoleit M, Dietrich AC, Ramspacher C, Steed E, Manet-Dupe S, Benz A, Hassel D, Vermot J, Huisken J, Tournier-Lasserve E, Felbor U, Sure U, Albiges-Rizo C, Abdelilah-Seyfried S (2015) Regulation of beta1 integrin-Klf2-mediated angiogenesis by CCM proteins. Dev Cell 32(2):181–190CrossRefPubMedGoogle Scholar
- Wustehube J, Bartol A, Liebler SS, Brutsch R, Zhu Y, Felbor U, Sure U, Augustin HG, Fischer A (2010) Cerebral cavernous malformation protein CCM1 inhibits sprouting angiogenesis by activating DELTA-NOTCH signaling. Proc Natl Acad Sci U S A 107(28):12640–12645CrossRefPubMedPubMedCentralGoogle Scholar
- Zheng X, Xu C, Di Lorenzo A, Kleaveland B, Zou Z, Seiler C, Chen M, Cheng L, Xiao J, He J, Pack MA, Sessa WC, Kahn ML (2010) CCM3 signaling through sterile 20-like kinases plays an essential role during zebrafish cardiovascular development and cerebral cavernous malformations. J Clin Invest 120(8):2795–2804CrossRefPubMedPubMedCentralGoogle Scholar